EMEA (Europe, Middle East and Africa) Tasigna Market Report 2017

August 2017 | 101 pages | ID: E24578FBD1DEN
QYResearch

Abstracts

In this report, the EMEA Tasigna market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Tasigna for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Tasigna market competition by top manufacturers/players, with Tasigna sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Novartis Pharma
• Merck
• AstraZeneca
• Harbin Pharmaceutical Group

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• 200 mg Capsule
• 150 mg Capsule

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Tasigna for each application, including

• Hospital
• Pharmacy

Contents

EMEA (Europe, Middle East and Africa) Tasigna Market Report 2017

1 TASIGNA OVERVIEW

1.1 Product Overview and Scope of Tasigna
1.2 Classification of Tasigna
  1.2.1 EMEA Tasigna Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Tasigna Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 200 mg Capsule
  1.2.4 150 mg Capsule
1.3 EMEA Tasigna Market by Application/End Users
  1.3.1 EMEA Tasigna Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital
  1.3.3 Pharmacy
1.4 EMEA Tasigna Market by Region
  1.4.1 EMEA Tasigna Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Tasigna (2012-2022)
  1.5.1 EMEA Tasigna Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Tasigna Revenue and Growth Rate (2012-2022)

2 EMEA TASIGNA COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Tasigna Market Competition by Players/Manufacturers
  2.1.1 EMEA Tasigna Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Tasigna Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Tasigna Sale Price by Players (2012-2017)
2.2 EMEA Tasigna (Volume and Value) by Type/Product Category
  2.2.1 EMEA Tasigna Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Tasigna Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Tasigna Sale Price by Type (2012-2017)
2.3 EMEA Tasigna (Volume) by Application
2.4 EMEA Tasigna (Volume and Value) by Region
  2.4.1 EMEA Tasigna Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Tasigna Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Tasigna Sales Price by Region (2012-2017)

3 EUROPE TASIGNA (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Tasigna Sales and Value (2012-2017)
  3.1.1 Europe Tasigna Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Tasigna Revenue and Growth Rate (2012-2017)
3.2 Europe Tasigna Sales and Market Share by Type
3.3 Europe Tasigna Sales and Market Share by Application
3.4 Europe Tasigna Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Tasigna Sales Volume by Countries (2012-2017)
  3.4.2 Europe Tasigna Revenue by Countries (2012-2017)
  3.4.3 Germany Tasigna Sales and Growth Rate (2012-2017)
  3.4.4 France Tasigna Sales and Growth Rate (2012-2017)
  3.4.5 UK Tasigna Sales and Growth Rate (2012-2017)
  3.4.6 Russia Tasigna Sales and Growth Rate (2012-2017)
  3.4.7 Italy Tasigna Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Tasigna Sales and Growth Rate (2012-2017)

4 MIDDLE EAST TASIGNA (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Tasigna Sales and Value (2012-2017)
  4.1.1 Middle East Tasigna Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Tasigna Revenue and Growth Rate (2012-2017)
4.2 Middle East Tasigna Sales and Market Share by Type
4.3 Middle East Tasigna Sales and Market Share by Application
4.4 Middle East Tasigna Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Tasigna Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Tasigna Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Tasigna Sales and Growth Rate (2012-2017)
  4.4.4 Israel Tasigna Sales and Growth Rate (2012-2017)
  4.4.5 UAE Tasigna Sales and Growth Rate (2012-2017)
  4.4.6 Iran Tasigna Sales and Growth Rate (2012-2017)

5 AFRICA TASIGNA (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Tasigna Sales and Value (2012-2017)
  5.1.1 Africa Tasigna Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Tasigna Revenue and Growth Rate (2012-2017)
5.2 Africa Tasigna Sales and Market Share by Type
5.3 Africa Tasigna Sales and Market Share by Application
5.4 Africa Tasigna Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Tasigna Sales Volume by Countries (2012-2017)
  5.4.2 Africa Tasigna Revenue by Countries (2012-2017)
  5.4.3 South Africa Tasigna Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Tasigna Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Tasigna Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Tasigna Sales and Growth Rate (2012-2017)

6 EMEA TASIGNA MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Novartis Pharma
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Tasigna Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novartis Pharma Tasigna Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Merck
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Tasigna Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Merck Tasigna Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 AstraZeneca
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Tasigna Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 AstraZeneca Tasigna Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Harbin Pharmaceutical Group
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Tasigna Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Harbin Pharmaceutical Group Tasigna Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview

7 TASIGNA MANUFACTURING COST ANALYSIS

7.1 Tasigna Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Tasigna

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Tasigna Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Tasigna Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA TASIGNA MARKET FORECAST (2017-2022)

11.1 EMEA Tasigna Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Tasigna Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Tasigna Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Tasigna Price and Trend Forecast (2017-2022)
11.2 EMEA Tasigna Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Tasigna Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Tasigna Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Tasigna Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Tasigna Sales Forecast by Type (2017-2022)
11.7 EMEA Tasigna Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Tasigna
Figure EMEA Tasigna Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Tasigna Sales Volume Market Share by Type (Product Category) in 2016
Figure 200 mg Capsule Product Picture
Figure 150 mg Capsule Product Picture
Figure EMEA Tasigna Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Tasigna by Application in 2016
Figure Hospital Examples
Figure Pharmacy Examples
Figure EMEA Tasigna Market Size (Million USD) by Region (2012-2022)
Figure Europe Tasigna Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Tasigna Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Tasigna Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Tasigna Revenue (Million USD) Status and Forecast by Countries
Figure Africa Tasigna Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Tasigna Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Tasigna Sales Volume and Growth Rate (2012-2022)
Figure EMEA Tasigna Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Tasigna Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Tasigna Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Tasigna Sales Share by Players (2012-2017)
Figure 2016 Tasigna Sales Share by Players
Figure 2017 Tasigna Sales Share by Players
Figure EMEA Tasigna Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Tasigna Revenue (Million USD) by Players (2012-2017)
Table EMEA Tasigna Revenue Share by Players (2012-2017)
Table 2016 EMEA Tasigna Revenue Share by Players
Table 2017 EMEA Tasigna Revenue Share by Players
Table EMEA Tasigna Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Tasigna Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Tasigna Sales Share by Type (2012-2017)
Figure Sales Market Share of Tasigna by Type (2012-2017)
Figure EMEA Tasigna Sales Market Share by Type (2012-2017)
Table EMEA Tasigna Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Tasigna Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Tasigna by Type in 2016
Table EMEA Tasigna Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Tasigna Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Tasigna Sales Share by Application (2012-2017)
Figure Sales Market Share of Tasigna by Application (2012-2017)
Figure EMEA Tasigna Sales Market Share by Application in 2016
Table EMEA Tasigna Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Tasigna Sales Share by Region (2012-2017)
Figure Sales Market Share of Tasigna by Region (2012-2017)
Figure EMEA Tasigna Sales Market Share in 2016
Table EMEA Tasigna Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Tasigna Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Tasigna by Region (2012-2017)
Figure EMEA Tasigna Revenue Market Share Regions in 2016
Table EMEA Tasigna Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Tasigna Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Tasigna Revenue and Growth Rate (2012-2017)
Table Europe Tasigna Sales (K Units) by Type (2012-2017)
Table Europe Tasigna Market Share by Type (2012-2017)
Figure Europe Tasigna Market Share by Type in 2016
Table Europe Tasigna Sales (K Units) by Application (2012-2017)
Table Europe Tasigna Market Share by Application (2012-2017)
Figure Europe Tasigna Market Share by Application in 2016
Table Europe Tasigna Sales (K Units) by Countries (2012-2017)
Table Europe Tasigna Sales Market Share by Countries (2012-2017)
Figure Europe Tasigna Sales Market Share by Countries (2012-2017)
Figure Europe Tasigna Sales Market Share by Countries in 2016
Table Europe Tasigna Revenue (Million USD) by Countries (2012-2017)
Table Europe Tasigna Revenue Market Share by Countries (2012-2017)
Figure Europe Tasigna Revenue Market Share by Countries (2012-2017)
Figure Europe Tasigna Revenue Market Share by Countries in 2016
Figure Germany Tasigna Sales (K Units) and Growth Rate (2012-2017)
Figure France Tasigna Sales (K Units) and Growth Rate (2012-2017)
Figure UK Tasigna Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Tasigna Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Tasigna Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Tasigna Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Tasigna Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Tasigna Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Tasigna Sales (K Units) by Type (2012-2017)
Table Middle East Tasigna Market Share by Type (2012-2017)
Figure Middle East Tasigna Market Share by Type (2012-2017)
Table Middle East Tasigna Sales (K Units) by Applications (2012-2017)
Table Middle East Tasigna Market Share by Applications (2012-2017)
Figure Middle East Tasigna Sales Market Share by Application in 2016
Table Middle East Tasigna Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Tasigna Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Tasigna Sales Volume Market Share by Countries in 2016
Table Middle East Tasigna Revenue (Million USD) by Countries (2012-2017)
Table Middle East Tasigna Revenue Market Share by Countries (2012-2017)
Figure Middle East Tasigna Revenue Market Share by Countries (2012-2017)
Figure Middle East Tasigna Revenue Market Share by Countries in 2016
Figure Saudi Arabia Tasigna Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Tasigna Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Tasigna Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Tasigna Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Tasigna Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Tasigna Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Tasigna Sales (K Units) by Type (2012-2017)
Table Africa Tasigna Sales Market Share by Type (2012-2017)
Figure Africa Tasigna Sales Market Share by Type (2012-2017)
Figure Africa Tasigna Sales Market Share by Type in 2016
Table Africa Tasigna Sales (K Units) by Application (2012-2017)
Table Africa Tasigna Sales Market Share by Application (2012-2017)
Figure Africa Tasigna Sales Market Share by Application (2012-2017)
Table Africa Tasigna Sales Volume (K Units) by Countries (2012-2017)
Table Africa Tasigna Sales Market Share by Countries (2012-2017)
Figure Africa Tasigna Sales Market Share by Countries (2012-2017)
Figure Africa Tasigna Sales Market Share by Countries in 2016
Table Africa Tasigna Revenue (Million USD) by Countries (2012-2017)
Table Africa Tasigna Revenue Market Share by Countries (2012-2017)
Figure Africa Tasigna Revenue Market Share by Countries (2012-2017)
Figure Africa Tasigna Revenue Market Share by Countries in 2016
Figure South Africa Tasigna Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Tasigna Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Tasigna Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Tasigna Sales (K Units) and Growth Rate (2012-2017)
Table Novartis Pharma Tasigna Basic Information List
Table Novartis Pharma Tasigna Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Pharma Tasigna Sales (K Units) and Growth Rate (2012-2017)
Figure Novartis Pharma Tasigna Sales Market Share in EMEA (2012-2017)
Figure Novartis Pharma Tasigna Revenue Market Share in EMEA (2012-2017)
Table Merck Tasigna Basic Information List
Table Merck Tasigna Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Tasigna Sales (K Units) and Growth Rate (2012-2017)
Figure Merck Tasigna Sales Market Share in EMEA (2012-2017)
Figure Merck Tasigna Revenue Market Share in EMEA (2012-2017)
Table AstraZeneca Tasigna Basic Information List
Table AstraZeneca Tasigna Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Tasigna Sales (K Units) and Growth Rate (2012-2017)
Figure AstraZeneca Tasigna Sales Market Share in EMEA (2012-2017)
Figure AstraZeneca Tasigna Revenue Market Share in EMEA (2012-2017)
Table Harbin Pharmaceutical Group Tasigna Basic Information List
Table Harbin Pharmaceutical Group Tasigna Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Harbin Pharmaceutical Group Tasigna Sales (K Units) and Growth Rate (2012-2017)
Figure Harbin Pharmaceutical Group Tasigna Sales Market Share in EMEA (2012-2017)
Figure Harbin Pharmaceutical Group Tasigna Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Tasigna
Figure Manufacturing Process Analysis of Tasigna
Figure Tasigna Industrial Chain Analysis
Table Raw Materials Sources of Tasigna Major Manufacturers in 2016
Table Major Buyers of Tasigna
Table Distributors/Traders List
Figure EMEA Tasigna Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Tasigna Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Tasigna Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Tasigna Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Tasigna Sales Market Share Forecast by Region (2017-2022)
Table EMEA Tasigna Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Tasigna Revenue Market Share Forecast by Region (2017-2022)
Table Europe Tasigna Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Tasigna Sales Market Share Forecast by Countries (2017-2022)
Table Europe Tasigna Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Tasigna Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Tasigna Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Tasigna Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Tasigna Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Tasigna Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Tasigna Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Tasigna Sales Market Share Forecast by Countries (2017-2022)
Table Africa Tasigna Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Tasigna Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Tasigna Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Tasigna Sales Market Share Forecast by Type (2017-2022)
Table EMEA Tasigna Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Tasigna Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources